Primary Open Angle Glaucoma and Cataracts Clinical Trial
Official title:
A Randomized, Double-Masked Clinical Trial of Phacoemulsification Compared With Phacoemulsification and Micro-Bypass Stent Implantation in Patients With POAG
Verified date | February 2009 |
Source | University of Turin, Italy |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ministry of Health |
Study type | Interventional |
This was a prospective, double-masked, 15-month clinical trial comparing efficacy of phacoemulsification alone to combined phacoemulsification and implantation of the iStent® trabecular micro-bypass stent in patients with primary open-angle glaucoma.
Status | Completed |
Enrollment | 36 |
Est. completion date | March 2008 |
Est. primary completion date | March 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - a previous diagnosis of POAG - an IOP of > 18 mm Hg at three separate visits if on one medication, or subjects on at least two medications with uncontrolled IOP on three separate visits. - all patients were deemed likely to follow surgeon instructions and were able to give informed consent. Exclusion Criteria: - any glaucoma diagnosis other than POAG - the presence of peripheral anterior synechiae (PAS) - a cloudy cornea likely to inhibit gonioscopic view of the angle - any previous ocular surgery - history of trauma or ocular surface disease - the presence of peripheral anterior synechiae (PAS) - a cloudy cornea likely to inhibit gonioscopic view of the angle |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Turin, Italy |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary outcomes included IOP and reduction in medication use. | 15 month | Yes |